1 Min Read
April 28 (Reuters) - Celyad SA:
* Celyad initiates second dose escalation in think trial in first US patient Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.